TY - JOUR AU - Weatherall, D. L. AU - Clegg, J. B. PY - 1996 DA - 1996// TI - Thalassemia: a global public health problem. JO - Nat Med VL - 2 UR - https://doi.org/10.1038/nm0896-847 DO - 10.1038/nm0896-847 ID - Weatherall1996 ER - TY - JOUR AU - Olivieri, N. AU - Brittenham, G. PY - 1997 DA - 1997// TI - Iron-chelating therapy and the treatment of thalassemia. JO - Blood VL - 89 ID - Olivieri1997 ER - TY - JOUR AU - Fosburg, M. AU - Nathan, D. G. PY - 1990 DA - 1990// TI - Treatment of Cooley's anemia. JO - Blood VL - 76 ID - Fosburg1990 ER - TY - JOUR AU - Giardini, C. PY - 1997 DA - 1997// TI - Treatment of beta thalassemia. JO - Curr Opin Hematol VL - 4 UR - https://doi.org/10.1097/00062752-199704020-00002 DO - 10.1097/00062752-199704020-00002 ID - Giardini1997 ER - TY - JOUR AU - Anderson, L. J. AU - Wonke, B. AU - Prescott, E. AU - Holden, S. AU - Walker, J. M. AU - Pennell, D. J. PY - 2002 DA - 2002// TI - Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassemia. JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)09740-4 DO - 10.1016/S0140-6736(02)09740-4 ID - Anderson2002 ER - TY - JOUR AU - Barman Balfour, J. AU - Foster, R. H. PY - 1999 DA - 1999// TI - Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases. JO - Drugs VL - 58 UR - https://doi.org/10.2165/00003495-199958030-00021 DO - 10.2165/00003495-199958030-00021 ID - Barman Balfour1999 ER - TY - JOUR AU - Addis, A. AU - Loebstein, R. AU - Koren, G. AU - Einarson, T. R. PY - 1999 DA - 1999// TI - Meta-analytic review of the clinical effectiveness of oral deferiprone (L1). JO - Eur J Clin Pharmacol VL - 55 UR - https://doi.org/10.1007/s002280050584 DO - 10.1007/s002280050584 ID - Addis1999 ER - TY - JOUR AU - Porter, J. PY - 1997 DA - 1997// TI - A risk-benefit assessment of iron-chelation therapy. JO - Drug Saf VL - 17 UR - https://doi.org/10.2165/00002018-199717060-00006 DO - 10.2165/00002018-199717060-00006 ID - Porter1997 ER - TY - JOUR AU - Olivieri, N. F. AU - Brittenham, G. M. AU - Armstrong, S. A. M. AU - Basran, R. K. AU - Daneman, R. AU - Daneman, N. AU - Iwanchko, R. M. AU - Talbot, A. L. AU - Koren, G. PY - 1995 DA - 1995// TI - First prospective randomized trial of the iron chelators deferiprone and deferoxamine. JO - Blood VL - 86 ID - Olivieri1995 ER - TY - JOUR AU - Olivieri, N. F. PY - 1996 DA - 1996// TI - Randomised trial of deferiprone (L1) and deferoxamine (DFO) in thalassemia major. JO - Blood VL - 88 ID - Olivieri1996 ER - TY - JOUR AU - Olivieri, N. F. AU - Brittenham, G. M. PY - 1997 DA - 1997// TI - Final results of the randomized trial of deferiprone (L1) and deferoxamine (DFO). JO - Blood VL - 90 ID - Olivieri1997 ER - TY - CHAP AU - Cao, A. AU - Gabutti, V. AU - Galanello, R. AU - Masera, G. AU - Modell, B. AU - di Palma, A. AU - Piga, A. AU - Vullo, C. AU - Wonke, B. PY - 1997 DA - 1997// TI - Management Protocol for the Treatment of Thalassemia Patients. BT - Nicosia, Cyprus: Thalassemia International Federation ID - Cao1997 ER - TY - JOUR AU - Hoffbrand, A. V. AU - Gorman, A. AU - Laulicht, M. AU - Garidi, M. AU - Economidou, J. AU - Georgipoulou, P. AU - Hussain, M. A. M. AU - Flynn, D. M. PY - 1979 DA - 1979// TI - Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(79)91721-5 DO - 10.1016/S0140-6736(79)91721-5 ID - Hoffbrand1979 ER - TY - JOUR AU - Janka, G. E. AU - Möhring, P. AU - Helmig, M. AU - Haas, R. J. AU - Betke, K. PY - 1981 DA - 1981// TI - Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload. JO - Eur J Pediatr VL - 137 UR - https://doi.org/10.1007/BF00443259 DO - 10.1007/BF00443259 ID - Janka1981 ER - TY - JOUR AU - Aldouri, M. A. AU - Wonke, B. AU - Hoffbrand, A. V. AU - Flynn, D. M. AU - Laulicht, M. AU - Fenton, L. A. AU - Scheuer, P. J. AU - Kibbler, C. C. AU - Allwood, C. A. AU - Brown, D. PY - 1987 DA - 1987// TI - Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. JO - J Clin Pathol VL - 40 UR - https://doi.org/10.1136/jcp.40.11.1353 DO - 10.1136/jcp.40.11.1353 ID - Aldouri1987 ER - TY - JOUR AU - Maurer, H. S. AU - Lloyd-Still, J. D. AU - Ingrisano, C. AU - Gonzalez-Crussi, F. AU - Honig, G. R. PY - 1988 DA - 1988// TI - A prospective evaluation of iron chelation therapy in children with severe ∃-thalassemia. A six-year study JO - American Journal of Diseases of Children VL - 142 UR - https://doi.org/10.1001/archpedi.1988.02150030057020 DO - 10.1001/archpedi.1988.02150030057020 ID - Maurer1988 ER - TY - JOUR AU - Olivieri, N. F. AU - Brittenham, G. M. AU - Matsui, D. AU - Berkovitch, M. AU - Blendis, L. M. AU - Cameron, R. G. AU - McClelland, R. A. AU - Liu, P. P. AU - Templeton, D. M. AU - Koren, G. PY - 1995 DA - 1995// TI - Iron-chelation therapy with oral deferiprone in patients with thalassemia major. JO - N Engl J Med VL - 332 UR - https://doi.org/10.1056/NEJM199504063321404 DO - 10.1056/NEJM199504063321404 ID - Olivieri1995 ER - TY - JOUR AU - Longo, F. AU - Fischer, R. AU - Engelhardt, R. AU - Nielsen, P. AU - Sacchetti, L. AU - Piga, A. PY - 1998 DA - 1998// TI - Iron balance in thalassemia patients treated with deferiprone. JO - Blood VL - 92 ID - Longo1998 ER - TY - JOUR AU - Mazza, P. AU - Amurri, B. AU - Lazzari, G. AU - Masi, C. AU - Palazzo, G. AU - Spartera, M. A. AU - Giua, R. AU - Sebastio, A. M. AU - Suma, V. AU - De Marco, S. PY - 1998 DA - 1998// TI - Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemia. JO - Haematologica VL - 83 ID - Mazza1998 ER - TY - JOUR AU - Olivieri, N. F. AU - Brittenham, G. M. AU - McLaren, C. E. AU - Templeton, D. M. AU - Cameron, R. G. AU - McClelland, R. A. AU - Burt, A. D. AU - Fleming, K. A. PY - 1998 DA - 1998// TI - Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199808133390701 DO - 10.1056/NEJM199808133390701 ID - Olivieri1998 ER - TY - JOUR AU - Töndury, P. AU - Zimmerman, A. AU - Nielsen, P. AU - Hirt, A. PY - 1998 DA - 1998// TI - Liver iron and fibrosis during long-term treatment with deferiprone in Swiss thalassaemic patients. JO - Br J Haematol VL - 101 UR - https://doi.org/10.1046/j.1365-2141.1998.00725.x DO - 10.1046/j.1365-2141.1998.00725.x ID - Töndury1998 ER - TY - JOUR AU - Diav-Citrin, O. AU - Atanackovic, G. AU - Koren, G. PY - 1999 DA - 1999// TI - An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major. JO - Ther Drug Monit VL - 21 UR - https://doi.org/10.1097/00007691-199902000-00011 DO - 10.1097/00007691-199902000-00011 ID - Diav-Citrin1999 ER - TY - JOUR AU - Cohen, A. PY - 1990 DA - 1990// TI - Current status of iron chelation therapy with deferoxamine. JO - Semin Hematol VL - 27 ID - Cohen1990 ER - TY - JOUR AU - Gabutti, V. AU - Piga, A. PY - 1996 DA - 1996// TI - Results of long-term iron-chelating therapy. JO - Acta Haematol VL - 95 UR - https://doi.org/10.1159/000203853 DO - 10.1159/000203853 ID - Gabutti1996 ER - TY - JOUR AU - Jensen, P. D. AU - Jensen, F. T. AU - Christensen, T. AU - Ellegaard, J. PY - 1995 DA - 1995// TI - Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients. JO - Br J Haematol VL - 89 UR - https://doi.org/10.1111/j.1365-2141.1995.tb08428.x DO - 10.1111/j.1365-2141.1995.tb08428.x ID - Jensen1995 ER - TY - JOUR AU - Olivieri, N. F. PY - 1999 DA - 1999// TI - The B-Thalassemias. JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199907083410207 DO - 10.1056/NEJM199907083410207 ID - Olivieri1999 ER - TY - JOUR AU - Brittenham, G. M. AU - Cohen, A. R. AU - McLaren, C. E. AU - Martin, M. B. AU - Griffith, P. M. AU - Nienhuis, A. W. AU - Young, N. S. AU - Allen, C. J. AU - Farrell, D. E. AU - Harris, J. W. PY - 1993 DA - 1993// TI - Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. JO - Am J Hematol VL - 42 UR - https://doi.org/10.1002/ajh.2830420116 DO - 10.1002/ajh.2830420116 ID - Brittenham1993 ER - TY - JOUR AU - Maggio, A. AU - D'Amico, G. AU - Morabito, A. AU - Capra, M. AU - Ciaccio, C. AU - Cianciulli, P. AU - Di Gregorio, F. AU - Garozzo, G. AU - Malizia, R. AU - Magnano, C. AU - Mangiagli, A. AU - Quarta, G. AU - Rizzo, M. AU - D'Ascola, D. G. AU - Rizzo, A. AU - Midiri, M. PY - 2002 DA - 2002// TI - Deferiprone versus deferoxamine in patients with thalassemia major: A randomized clinical trial. JO - Blood Cells, Molecules, and Diseases VL - 28 UR - https://doi.org/10.1006/bcmd.2002.0510 DO - 10.1006/bcmd.2002.0510 ID - Maggio2002 ER - TY - STD TI - Meta-analysis under scrutiny. Editorial. Lancet. 1997, 350: 675-10.1016/S0140-6736(97)21036-6. ID - ref29 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2326/2/4/prepub UR - http://www.biomedcentral.com/1471-2326/2/4/prepub ID - ref30 ER -